Virtus Investment Advisers »

Sarepta Therapeutics note 1.500% 11/1 shares owned by Virtus Investment Advisers

Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Virtus Investment Advisers from 13F filings

Historical chart of Virtus Investment Advisers investment in Sarepta Therapeutics note 1.500% 11/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics note 1.500% 11/1 held by Virtus Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Virtus Investment Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.7k 4.0k 1.41

More positions owned by Virtus Investment Advisers

Pimco Etf Tr Enhancd Short (EMNT)
Virtus Etf Tr Ii Duff & Phelps Cl (VCLN)
Vipshop Hldgs Sponsored Ads A (VIPS)
Icici Bank Adr (IBN)
Coca-Cola Bottling Co. Consolidated (COKE)
Apple (AAPL)
Microsoft Corporation (MSFT)
Warrior Met Coal (HCC)
Boise Cascade (BCC)
NVIDIA Corporation (NVDA)
Barrett Business Services (BBSI)
Rush Enterprises Cl A (RUSHA)
Gulfport Energy Corp Common Shares (GPOR)
Janus International Group In Common Stock (JBI)
Prestige Brands Holdings (PBH)

View all positions for Virtus Investment Advisers

Top funds holding Sarepta Therapeutics note 1.500% 11/1

DLD Asset Management
Point72 Asset Management
D. E. Shaw & Co
CSS
Capstone Investment Advisors
Worth Venture Partners
Bank of America Corporation
Palisade Capital Management
Warberg Asset Management
Wolverine Asset Management
Bnp Paribas Arbitrage, Snc
Fox Hill Wealth Management
Virtus Investment Advisers
Royal Bank of Canada
Citigroup

View all funds holding Sarepta Therapeutics note 1.500% 11/1